4.7 Article

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis

Sanjana Balachandra et al.

Summary: This study found that HPV-16 E6 antibodies and circulating HPV-16 DNA are the most representative and promising blood-based biomarkers for HPV-associated cancers. Comparative validity analyses are needed, and further research on biomarkers targeting more high-risk HPV types is warranted.

CANCER (2021)

Article Pathology

Oropharyngeal Squamous Cell Carcinoma With Discordant p16 and HPV mRNA Results Incidence and Characterization in a Large, Contemporary United States Cohort

Justin R. Shinn et al.

Summary: The study found a high positivity rate of p16 and HPV mRNA in oropharyngeal squamous cell carcinoma patients, with those who had concordant testing results showing higher survival rates. While patients with discordant testing results had survival rates falling between the two concordant groups, there was no significant difference found in outcomes in multivariate analysis.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Oncology

The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma

Irene H. Nauta et al.

Summary: The prevalence of HPV in oral cavity squamous cell carcinoma is low, and neither HPV status nor p16 status affects outcome, making it seem irrelevant for clinical management to determine HPV status in OCSCC.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes

Lalida Arsa et al.

Summary: The prevalence of HPV infection and p16 expression is lower in Thai patients with HNSCC compared to Western countries. p16 is a significant prognostic factor for OS in both HPV-associated oropharyngeal squamous cell carcinoma and non-OPSCC. Detection of HPV should be performed regardless of p16 expression in order to assess the association with HNSCC.

BMC CANCER (2021)

Article Oncology

The Clinical Value of Measuring Circulating HPV DNA during Chemo-Radiotherapy in Squamous Cell Carcinoma of the Anus

Anna C. Lefevre et al.

Summary: In anal cancer patients, HPV infection can be a predictor of treatment failure, with different subtypes showing correlation with elimination patterns and treatment outcomes. Detection of HPV DNA in blood samples can potentially assist in predicting local and distant treatment failures, providing valuable clinical information for decision-making.

CANCERS (2021)

Article Otorhinolaryngology

Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer

Nina Burbure et al.

Summary: This study analyzed treatment patterns and survival of hypopharynx cancer using the NCDB, finding that surgery yields improved survival for T4 disease, while treatment modality does not impact outcomes for other T-stages. HPV-positive tumors are associated with improved survival regardless of treatment.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)

Article Multidisciplinary Sciences

Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma

Chrystiano de C. Ferreira et al.

Summary: This study found that drinkers and current smokers were less likely to be p16 positive. Female sex, higher education level, and younger age at diagnosis were associated with a higher probability of being p16 positive. Additionally, a higher proportion of patients in the p16 positive group had early clinical stage (I or II) compared to the p16 negative group.

PLOS ONE (2021)

Article Virology

Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas

Andrejs Lifsics et al.

Summary: The study found a high prevalence of HPV16 in laryngeal and hypopharyngeal squamous cell carcinoma, but the lack of HPV E6/E7 oncoproteins in some tumor samples may suggest the presence of other mechanisms of tumorigenesis.

VIRUSES-BASEL (2021)

Article Health Care Sciences & Services

Malignancy Prediction Capacity and Possible Prediction Model of Circulating Tumor Cells for Suspicious Pulmonary Lesions

Ching-Yang Wu et al.

Summary: This study aimed to establish a malignancy prediction model based on tumor presentations, finding that tumor size and circulating tumor cells (CTC) were key indicators for predicting malignancy. The combined malignancy prediction model showed potential predictive value, with a calculated probability of malignancy reaching 97.9% in patients with tumor size >= 0.7 cm and CTC > 3.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Review Otorhinolaryngology

P16 and human papillomavirus in sinonasal squamous cell carcinoma

Erin Cohen et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

Article Oncology

Head and Neck Cancers, Version 2.2020

David G. Pfister et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Article Otorhinolaryngology

The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer

Hung-Ming Wang et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)

Article Multidisciplinary Sciences

HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study

Panagiota Economopoulou et al.

PLOS ONE (2019)

Review Otorhinolaryngology

Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy

Jason Chia-Hsun Hsieh et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)

Article Oncology

Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer

Alex K. Bryant et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Oncology

Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer

Alex K. Bryant et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Cell Biology

Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker

Xuehui Zhang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Dual role for p16 in the metastasis process of HPV positive head and neck cancers

Ruveyda Dok et al.

MOLECULAR CANCER (2017)

Article Otorhinolaryngology

Prognostic significance of p16 in squamous cell carcinoma of the larynx and hypopharynx

Jessica Meshman et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2017)

Article Otorhinolaryngology

Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma

Jason Chia-Hsun Hsieh et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)

Article Otorhinolaryngology

Presence of human papillomaviruses and p16 expression in hypopharyngeal cancer

Malin Wendt et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)

Article Otorhinolaryngology

Epidemiology of Human Papillomavirus-Related Head and Neck Cancer

Andrew W. Joseph et al.

OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2012)

Article Medicine, General & Internal

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Oncology

Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer

Niklas Reimers et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Review Oncology

Clinical implications of human papillomavirus in head and neck cancers

Carole Fakhry et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Article Medicine, General & Internal

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

J Mork et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)